BioMidwest

Found 78,937 articles

• 

  BioSpace Launches 2022 Hotbed Maps to Highlight Thriving Life Sciences Clusters

  1/18/2022

  As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.

• Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology

  5/22/2023

  Royal Philips, a global leader in health technology, and Vanderbilt University Medical Center, home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., announced a collaboration that aims to reduce the health system’s carbon footprint while determining a blueprint to guide industry efforts.

• Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development

  5/22/2023

  Creative Medical Technology Holdings, Inc. announced significant advances in the ongoing development of its ImmCelz® platform, the Company's cell-free system which has previously been validated to supercharge a patient's own cells to treat a number of immune disorders.

• Ken Reali, Renowned Healthcare Executive, Joins NeoLight's Board of Directors

  5/22/2023

  NeoLight is pleased to announce the appointment of Ken Reali, a respected healthcare executive, to its Board of Directors.

• Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer

  5/22/2023

  Panbela Therapeutics, Inc. today announced it has entered into a clinical trial agreement with Moffitt Cancer Center for a Phase I/II program in STK11 mutant non-small cell lung cancer (NSCLC).

• Nordson Corporation Reports Second Quarter Fiscal 2023 Results and Updates Annual Guidance

  5/22/2023

  Nordson Corporation reported results for the fiscal second quarter ended April 30, 2023. Sales were $650 million, a 2% increase compared to the prior year’s second quarter sales of $635 million.

• Endotronix Extends Positive Outcomes with 12-month Data Release from the SIRONA 2 Trial for Remote Heart Failure Management Using the Cordella Pulmonary Artery Sensor

  5/22/2023

  Endotronix, Inc. today announced positive 12-month data from the SIRONA 2 clinical trial that demonstrated long-term use of the Cordella Pulmonary Artery (PA) Sensor was associated with significant improvements in patient quality-of-life metrics and low HF hospitalization and death (HFH/D) event rates for New York Heart Failure (NYHA) class III patients.

• Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at Market

  5/22/2023

  Navidea Biopharmaceuticals, Inc. announced the sale of Preferred Shares totaling $1.1 million to new existing investors, further supporting the Company’s Fix, Fund, Propel approach and helping to advance Navidea’s innovative technology to market.

• Foundation for Sarcoidosis Research Releases White Paper and Hosts Congressional Briefing on Advancing Clinical Trial Equity for Black Patients with Sarcoidosis

  5/22/2023

  Foundation for Sarcoidosis Research is proud to announce the release of the Ignore No More Campaign on Clinical Trials Diversity:Advancing Clinical Trial Equity for Black Patients with Sarcoidosis White Paper which summarizes the findings and recommendations from an IRB-approved national survey of Black Americans to get a better understanding of the challenges and experiences they face in considering and participating in clinical trials.

• Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer

  5/22/2023

  Lifecore Biomedical, Inc. announced that it has entered into a broad set of agreements with its long-term customer, Alcon, which provides for the repayment of the Company’s existing credit agreement with its current lenders and substantially increases the amount of hyaluronic acid that Lifecore is expected to supply for use in Alcon’s commercial products.

• Exactech Announces First Total Ankle Surgeries in South America

  5/22/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced first surgeries in Latin America with the Vantage® Total Ankle Fixed Bearing System.

• Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT

  5/22/2023

  Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization, announced that it will host a conference call to discuss fiscal 2023 third quarter financial results.

• Lilly ESG Report Highlights Progress Towards Sustainability Goals

  5/22/2023

  Eli Lilly and Company released its latest Environmental, Social and Governance report showing progress towards the company's ambitious sustainability goals, which are critical to maintaining a strong and resilient company.

• IDEX Corporation Completes Acquisition of Iridian Spectral Technologies

  5/22/2023

  IDEX Corporation announced that it has completed its previously-announced acquisition of Iridian Spectral Technologies, a global leader in designing and manufacturing thin-film, multi-layer optical filters.

• Abeona Therapeutics Announces Date Change for First Quarter 2023 Portfolio Update Conference Call to May 24, 2023

  5/22/2023

  Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has changed the date of its previously announced First Quarter 2023 Portfolio Update conference call and webcast to Wednesday, May 24, 2023, at 8:30 a.m. ET. The call was previously scheduled for Tuesday, May 23, 2023, at 8:30 a.m. ET.

• ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference

  5/22/2023

  ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Healthcare Conference in New York City.         8:30

• Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness

  5/20/2023

  Medtronic plc, a global leader in healthcare technology, announced longer-term follow-up results of its investigational EV ICD™ System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.

• Endsulin Announces Passing of Founder Hans Sollinger, MD, PhD

  5/19/2023

  Endsulin announced that Founder and Chief Scientific Officer Hans Sollinger, M.D., Ph.D., passed away peacefully on May 15, 2023, after a recurrence of a previous illness.

• EPKINLY™ (epcoritamab-bysp) Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  5/19/2023

  AbbVie announced that the U.S. Food and Drug Administration has approved EPKINLYTM, as the first and only T-cell engaging bispecific antibody for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B–cell lymphoma, after two or more lines of systemic therapies.

• Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023

  5/19/2023

  Daewoong Pharmaceutical (CEO Lee Chang -jae and Jeon Sengho) announced on the 19th that that they set up a booth at the Digestive Disease Week® 2023 (DDW 2023) held in Chicago, USA and revealed new clinical data through two poster sessions demonstrating the efficacy and safety of Fexuclue® (active ingredient name: Fexuprazan) on patients with gastroesophageal reflux disease (GERD).